Cargando…
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
Pancreatic ductal adenocarcinoma (PDAC) is one of the most overlooked cancers despite its dismal median survival time of 6 months. The biggest challenges in improving patient survival are late diagnosis due to lack of diagnostic markers, and limited treatment options due to almost complete therapy r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569794/ https://www.ncbi.nlm.nih.gov/pubmed/34746135 http://dx.doi.org/10.3389/fcell.2021.741162 |